Iris Helfrich

机构：German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, Ludwig-Maximilians-Universität München · ORCID：0000-0001-6150-9570

发表论文 150 篇 · 总被引 5161 次 · h-index 34

代表论文

• Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (2023 · Nature Cancer · 被引 68)
• T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels (2024 · Immunity · 被引 23)
• Identification and characterization of tertiary lymphoid structures in brain metastases (2025 · Acta Neuropathologica Communications · 被引 13)
• Structure-based discovery of first inhibitors targeting the helicase activity of human PIF1 (2024 · Nucleic Acids Research · 被引 10)
• ComplexEye: a multi-lens array microscope for high-throughput embedded immune cell migration analysis (2023 · Nature Communications · 被引 9)
• Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma (2024 · British Journal of Dermatology · 被引 7)